Exciting change is on the way! Please join us at nsf.gov for the latest news on NSF-funded research. While the NSF Science360 page and daily newsletter have now been retired, there’s much happening at nsf.gov. You’ll find current research news on the homepage and much more to explore throughout the site. Best of all, we’ve begun to build a brand-new website that will bring together news, social media, multimedia and more in a way that offers visitors a rich, rewarding, user-friendly experience.

Want to continue to receive email updates on the latest NSF research news and multimedia content? On September 23rd we’ll begin sending those updates via GovDelivery. If you’d prefer not to receive them, please unsubscribe now from Science360 News and your email address will not be moved into the new system.

Thanks so much for being part of the NSF Science360 News Service community. We hope you’ll stay with us during this transition so that we can continue to share the many ways NSF-funded research is advancing knowledge that transforms our future.

For additional information, please contact us at NewsTravels@nsf.gov

Top Story

Balance gait negatively impacted after chemotherapy treatment

A single chemotherapy treatment can result in a significant negative impact on walking gait and balance, putting patients at an increasing risk for falls, according to a new study involving breast cancer patients. Up to 60 percent of patients experience chemotherapy-induced peripheral neuropathy, nerve damage that impacts feeling in the hands or feet; however, when and to what extent this damage impacts functional abilities has been largely unknown. This new study is the first to objectively measure the functional abilities of cancer patients during and after taxane-based chemotherapy.

Visit Website | Image credit: The Ohio State University